CIRM Awards $25M in Grants To Help Develop New Treatments
The California Institute for Regenerative Medicine has awarded $25 million in grants to support early stage research on using or targeting stem cells to treat seven disorders, the Sacramento Business Journal reports (Robertson, Sacramento Business Journal, 3/27).
Details of Grants
The grants were awarded to:
- Darryl D'Lima of Scripps Health, who received about $7.6 million to research osteochondral defects;
- Rivkah Isseroff of UC-Davis, who received about $5 million to research diabetic wounds;
- Leslie Thomson of UC-Irvine, who received about $4.95 million to research Huntington's disease;
- Peter Schultz of the California Institute for Biomedical Research, who received about $2.6 million to study osteoarthritis;
- Diana Farmer of UC-Davis, who received about $2.1 million to research spina bifida;
- David Schubert of the Salk Institute for Biological Studies, who received about $1.7 million to study Alzheimer's disease; and
- Matthew Porteus of Stanford University, who received $1 million to research severe combined immunodeficiency (CIRM release, 3/26).
Jonathan Thomas, chair of the CIRM board, said, "These projects all showed compelling evidence that they could be tremendously beneficial to patients," adding, "We want to help them build on that earlier research and move the projects to the next level" (Sacramento Business Journal, 3/27).This is part of the California Healthline Daily Edition, a summary of health policy coverage from major news organizations. Sign up for an email subscription.